6533b834fe1ef96bd129e06b
RESEARCH PRODUCT
Perspective: Cancer Patient Management Challenges During the COVID-19 Pandemic
Daniela TerraccianoCarlo BuonerbaCarlo BuonerbaLuca ScafuriLuca ScafuriPiergiuseppe De BerardinisGeorge A. CalinAlessandra FerrajoliMuller FabbriAmelia Cimminosubject
0301 basic medicineCancer ResearchCoronavirus disease 2019 (COVID-19)Best practiceDiseasechemotherapylcsh:RC254-28203 medical and health sciences0302 clinical medicineNursingPolitical scienceHealth carePandemicmedicinecancersevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Everyday lifebusiness.industrypandemicPerspective (graphical)Cancerlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.disease030104 developmental biologyOncology030220 oncology & carcinogenesisPerspectivecoronavirus disease 2019 (COVID-19)businessdescription
On March 11, 2020, the WHO has declared the coronavirus disease 2019 (COVID-19) a global pandemic. As the last few months have profoundly changed the delivery of health care in the world, we should recognize the effort of numerous comprehensive cancer centers to share experiences and knowledge to develop best practices to care for oncological patients during the COVID-19 pandemic. Patients as well as physicians must be aware of all these constraints and profound social, personal, and medical challenges posed by the tackling of this deadly disease in everyday life in order to adjust to such a completely novel scenario. This review will discuss facing the challenges and the current approaches that cancer centers in Italy and United States are adopting in order to cope with clinical and research activities.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2020-08-01 | Frontiers in Oncology |